07/01/2025
12:52 PM | De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
12:56 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Walsh Angela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
12:58 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:00 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Duncan Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:02 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:05 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Grosswald Ralph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:07 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:11 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Gendreau Roger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:01 PM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/24/2025
9:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
10:57 AM | De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VIRI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
10:59 AM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
11:02 AM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
11:04 AM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
11:15 PM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form EFFECT | |
05/23/2025
4:25 PM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/09/2025
10:28 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
8:20 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
1:08 PM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form ARS | |
04/30/2025
7:00 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form DEF 14A | |
04/03/2025
8:10 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
3:44 PM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
7:19 PM | Conjoint Inc. (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
8:11 PM | Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Sealbond Ltd (Filed by)
| Form SCHEDULE 13D/A | |
03/17/2025
8:07 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:53 PM | Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G/A | |
03/17/2025
4:49 PM | Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G | |
03/14/2025
10:47 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
9:32 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 424B5 | |
03/12/2025
8:00 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
8:30 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K/A | |
11/21/2024
8:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
8:25 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:29 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Toh Kean Meng Melvin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:30 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Yu Ying Choi Alan Abel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:29 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Sealbond Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/15/2024
3:19 PM | Sealbond Ltd (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
| Form SC 13D | |
10/07/2024
7:06 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEFA14A | |
10/07/2024
7:02 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
5 Stocks Poised to Soar Under Trump's Presidency (Ad) With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape.
For investors who position early, the opportunities could be significant.
That’s why we’ve just released a brand-new report:
📈 “5 Best Stocks to Buy Under Trump’s Presidency.” Get the full report here—and stay ahead of the curve. |
08/09/2024
9:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:30 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
